Tumor DNA in blood may serve as prognostic marker of pancreatic cancer
The presence of circulating tumor DNA (ctDNA) isolated from blood samples of patients with pancreatic adenocarcinoma was associated with poor outcomes.
Dec 19, 2016
The presence of circulating tumor DNA (ctDNA) isolated from blood samples of patients with pancreatic adenocarcinoma was associated with poor outcomes.
Dec 19, 2016
Bottom Line: Among women with breast cancer who received a type of chemotherapy called an anthracycline, those who had a certain genetic biomarker had a significantly increased risk for having anthracycline-induced congestive ...
Dec 19, 2016
Using cardiac imaging during heart surgery can detect serious residual holes in the heart that may occur when surgeons repair a child's heart defect, and offers surgeons the opportunity to close those holes during the same ...
Dec 19, 2016